581 748

Cited 0 times in

골수형성이상증후군

DC Field Value Language
dc.contributor.author민유홍-
dc.contributor.author정준원-
dc.date.accessioned2015-06-10T12:56:02Z-
dc.date.available2015-06-10T12:56:02Z-
dc.date.issued2006-
dc.identifier.issn1975-8456-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/110710-
dc.description.abstractMyelodysplastic syndrome (MDS) is a clonal stem cell disorder characterized by ineffective hematopoiesis, multilineage dysplasia, peripheral cytopenias with normocellular or hypercellular marrow, and susceptibility to leukemic transformation. MDS represents a heterogenous group of disorders with a wide spectrum of clinical, morphological, biologic, and genetic characteristics. MDS is classified according to the World Health Organization criteria and the International Prognostic Scoring System. Risk-adapted treatment strategies have been developed in consideration of the advanced age of patients and to improve the clinical course of the disease. The pathophysiology, cytogenetic/molecular profiles, clinical characteristics and treatment modalities according to the prognostic groups will be described. In the future, a combination of treatment modalities to increase gene reactivation and to take advantage of increased expression of target genes may be critical to improve clinical outcomes. Multiple pathways may be involved in the MDS phenotype, and combination therapies, including novel agents, may be required to make further progresses in the treatment of this disease.-
dc.description.statementOfResponsibilityopen-
dc.format.extent897~907-
dc.languageJOURNAL OF THE KOREAN MEDICAL ASSOCIATION-
dc.publisherJOURNAL OF THE KOREAN MEDICAL ASSOCIATION-
dc.relation.isPartOfJOURNAL OF THE KOREAN MEDICAL ASSOCIATION-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.title골수형성이상증후군-
dc.title.alternativeMyelodysplastic Syndrome-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학)-
dc.contributor.googleauthor정준원-
dc.contributor.googleauthor민유홍-
dc.identifier.doi10.5124/jkma.2006.49.10.897-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA01407-
dc.contributor.localIdA03729-
dc.relation.journalcodeJ01833-
dc.identifier.eissn2093-5951-
dc.subject.keywordMyelodysplastic syndrome-
dc.subject.keywordPathophysiology-
dc.subject.keywordDiagnosis-
dc.subject.keywordClassification-
dc.subject.keywordTreatment-
dc.contributor.alternativeNameMin, Yoo Hong-
dc.contributor.alternativeNameCheong, June Won-
dc.contributor.affiliatedAuthorMin, Yoo Hong-
dc.contributor.affiliatedAuthorCheong, June-Won-
dc.rights.accessRightsfree-
dc.citation.volume49-
dc.citation.number10-
dc.citation.startPage897-
dc.citation.endPage907-
dc.identifier.bibliographicCitationJOURNAL OF THE KOREAN MEDICAL ASSOCIATION, Vol.49(10) : 897-907, 2006-
dc.identifier.rimsid50163-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.